BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12058256)

  • 1. Inhibitors in the NFkappaB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations.
    Miterski B; Böhringer S; Klein W; Sindern E; Haupts M; Schimrigk S; Epplen JT
    Genes Immun; 2002 Jun; 3(4):211-9. PubMed ID: 12058256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association study between exon 4 NFKBIL1 polymorphism and multiple sclerosis].
    Owecki MK; Kowal P; Kaczmarek-Ryśs M; Hoppe-Gołebiewska J; Nikisch E; Tokarz-Kupczyk E; Słomski R; Kozubski W
    Pol Merkur Lekarski; 2010 May; 28(167):366-70. PubMed ID: 20568399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interferon gene cluster: a candidate region for MS predisposition? Multiple Sclerosis Study Group.
    Miterski B; Jaeckel S; Epplen JT; Pöhlau D; Hardt C
    Genes Immun; 1999 Sep; 1(1):37-44. PubMed ID: 11197304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha-308 gene polymorphism in Croatian and Slovenian multiple sclerosis patients.
    Ristić S; Lovrecić L; Starcević-Cizmarević N; Brajenović-Milić B; Sega Jazbec S; Sepcić J; Kapović M; Peterlin B
    Eur Neurol; 2007; 57(4):203-7. PubMed ID: 17268200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic risk factors in multiple sclerosis and approaches to their identification.
    Rasmussen HB; Clausen J
    J Neurovirol; 2000 May; 6 Suppl 2():S23-7. PubMed ID: 10871780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility.
    Fernandez-Morera JL; Rodriguez-Rodero S; Tunon A; Martinez-Borra J; Vidal-Castineira JR; Lopez-Vazquez A; Rodrigo L; Rodrigo P; González S; Lahoz CH; Lopez-Larrea C
    Tissue Antigens; 2008 Jul; 72(1):54-9. PubMed ID: 18588574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of a genetic variation of a variable number tandem repeat polymorphism of interleukin-6 gene in patients with multiple sclerosis.
    Schmidt S; Papassotiropoulos A; Sotgiu S; Kölsch H; Arru G; Fois ML; Haase CG; Schmitz S; König N; Harzheim M; Heun R; Klockgether T
    J Neurol; 2003 May; 250(5):607-11. PubMed ID: 12736743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical behavior of multiple sclerosis is modulated by the MHC class I-chain-related gene A.
    Fdez-Morera JL; Tunon A; Rodriguez-Rodero S; Rodrigo L; Martinez-Borra J; Gonzalez S; Lopez-Vazquez A; Lahoz CH; Lopez-Larrea C
    Tissue Antigens; 2006 May; 67(5):409-14. PubMed ID: 16671949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians.
    Burfoot RK; Jensen CJ; Field J; Stankovich J; Varney MD; Johnson LJ; Butzkueven H; Booth D; Bahlo M; Tait BD; Taylor BV; Speed TP; Heard R; Stewart GJ; Foote SJ; Kilpatrick TJ; Rubio JP
    Tissue Antigens; 2008 Jan; 71(1):42-50. PubMed ID: 17971048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRYAB promoter polymorphisms: influence on multiple sclerosis susceptibility and clinical presentation.
    Stoevring B; Frederiksen JL; Christiansen M
    Clin Chim Acta; 2007 Jan; 375(1-2):57-62. PubMed ID: 17010329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the HLA-DRB1*15 allele group and the DRB1*1501 and DRB1*1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil.
    Brum DG; Barreira AA; Louzada-Junior P; Mendes-Junior CT; Donadi EA
    J Neuroimmunol; 2007 Sep; 189(1-2):118-24. PubMed ID: 17681614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
    Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
    Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population.
    Tajouri L; Ovcaric M; Curtain R; Johnson MP; Griffiths LR; Csurhes P; Pender MP; Lea RA
    J Neurogenet; 2005; 19(1):25-38. PubMed ID: 16076630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environment-gene interaction in multiple sclerosis: human herpesvirus 6 and MHC2TA.
    Martínez A; Alvarez-Lafuente R; Mas A; Bartolomé M; García-Montojo M; de Las Heras V; de la Concha EG; Arroyo R; Urcelay E
    Hum Immunol; 2007 Aug; 68(8):685-9. PubMed ID: 17678724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis.
    Harbo HF; Lie BA; Sawcer S; Celius EG; Dai KZ; Oturai A; Hillert J; Lorentzen AR; Laaksonen M; Myhr KM; Ryder LP; Fredrikson S; Nyland H; Sørensen PS; Sandberg-Wollheim M; Andersen O; Svejgaard A; Edland A; Mellgren SI; Compston A; Vartdal F; Spurkland A
    Tissue Antigens; 2004 Mar; 63(3):237-47. PubMed ID: 14989713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility.
    Márquez A; Cénit MC; Núñez C; Mendoza JL; Taxonera C; Díaz-Rubio M; Bartolomé M; Arroyo R; Fernández-Arquero M; de la Concha EG; Urcelay E
    Genes Immun; 2009 Oct; 10(7):631-5. PubMed ID: 19657358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic influence of the nonclassical MHC molecule HLA-G on multiple sclerosis.
    Kroner A; Grimm A; Johannssen K; Mäurer M; Wiendl H
    Hum Immunol; 2007 May; 68(5):422-5. PubMed ID: 17462509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL23R: a susceptibility locus for celiac disease and multiple sclerosis?
    Núñez C; Dema B; Cénit MC; Polanco I; Maluenda C; Arroyo R; de las Heras V; Bartolomé M; de la Concha EG; Urcelay E; Martínez A
    Genes Immun; 2008 Jun; 9(4):289-93. PubMed ID: 18368064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.